ChemBK
  • Home
  • Product Category
  • CHN
  1. Home
  2. CAS 117678-38-3
  3. Supplier List
  4. MedChemExpress (MCE)
  5. Signaling Pathways
  6. Levofloxacin N-oxide

Request for quotation








Supplier Contact

Supplier NameMedChemExpress (MCE)
Contactsales
Tel609-228-6898
Mobile609-228-6898
QQ
Emailsales@medchemexpress.com; tech@medchemexpress.com
Websitehttps://www.medchemexpress.com/
Wechat
Product Name(S)-4-(6-carboxy-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-10-yl)-1-methylpiperazine 1-oxide
SynonymsLevofloxacin-3
(S)-4-(6-carboxy-9
Levofloxacin N-oxide
Levofloacin Impurity 2
Levofloxacin EP Impurity C (Levofloxacin N-Oxide)
1-Methyl-4-[(9-fluoro-2,3-dihydro-6-carboxy-3α-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazin)-10-yl]piperazine 1-oxide

Synonyms

Levofloxacin-3
(S)-4-(6-carboxy-9
Levofloxacin N-oxide
Levofloacin Impurity 2
Levofloxacin EP Impurity C (Levofloxacin N-Oxide)
1-Methyl-4-[(9-fluoro-2,3-dihydro-6-carboxy-3α-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazin)-10-yl]piperazine 1-oxide
(S)-4-(6-carboxy-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-10-yl)-1-methylpiperazine 1-oxide
CAS117678-38-3
EINECS
Chemical FormulaC18H20FN3O5
Molecular Weight377.3669032
inchi
Package10 mM * 1 mL;1 mg;5 mg;10 mg;25 mg;50 mg;100 mg
PriceEmail to quote
DescriptionsLevofloxacin N-oxide

Levofloxacin N-oxide

MedChemExpress (MCE)

HY-133787

117678-38-3

98.28%

4°C, protect from light *In solvent : -80°C, 6 months

Descriptions

Levofloxacin N-oxide

Levofloxacin N-oxide

MedChemExpress (MCE)

HY-133787

117678-38-3

98.28%

4°C, protect from light *In solvent : -80°C, 6 months
-20°C, 1 month (protect from light)

Room temperature in continental US
may vary elsewhere.

Levofloxacin N-oxide is a minor metabolite of Levofloxacin (HY-B0330). Levofloxacin N-oxide does not exhibit significantly genotoxic risks. Levofloxacin is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria.

| | | |

| | | | | |



[1]. Zhu Q, et al. In silico and in vitro genotoxicity evaluation of levofloxacin n-oxide, an impurity in levofloxacin. Toxicol Mech Methods. 2012 Apr
22(3):225-30.
[Content Brief]

[2]. Nightingale CH, et al. Pharmacodynamics and pharmacokinetics of levofloxacin. Chemotherapy. 2000
46 Suppl 1:6-14.
[Content Brief]

Supplier Websitehttps://www.medchemexpress.com/levofloxacin-n-oxide.html
Last Update2025-05-21 16:50:25
MedChemExpress (MCE) also provides

Thalidomide-4-O-C2-NH2

Category: Signaling Pathways
CAS: 2341840-99-9
Last Update: 2025-05-21 16:50:25

PPARα-MO-1

Category: Signaling Pathways
CAS: 810677-36-2
Last Update: 2025-05-21 16:50:25

Netupitant N-oxide

Category: Signaling Pathways
CAS: 910808-11-6
Last Update: 2025-05-21 16:50:25

MK-0812

Category: Signaling Pathways
CAS: 624733-88-6
Last Update: 2025-05-21 16:50:25

TS-011

Category: Signaling Pathways
CAS: 339071-18-0
Last Update: 2025-05-21 16:50:25

SCH 530348 sulfate

Category: Signaling Pathways
CAS: 705260-08-8
Last Update: 2025-05-21 16:50:25

BAG 956

Category: Signaling Pathways
CAS: 853910-02-8
Last Update: 2025-05-21 16:50:25

YM758

Category: Signaling Pathways
CAS: 312752-85-5
Last Update: 2025-05-21 16:50:25
  • Home
  • Product Category

© 2015 ChemBK.com All Rights Reserved | Build: 20150530002